Title
Long-term survival in patients discharged alive from hospital following an intensive care unit admission with sepsis or septic shock in Australia and New Zealand: an observational cohort study
Author(s)
Wah, Win
Poole, Alexis Paul
Cohen, Jeremy
Cooper, Jamie
Deane, Adam
Delaney, Anthony
Eastwood, Glenn
Finfer, Simon
French, Craig
Haines, Kimberley
Hammond, Naomi
Higgins, Alisa
Hodgson, Carol
Jones, Daryl
Litton, Edward
McQuilten, Zoe
Neto, Ary Serpa
Pilcher, David
Peake, Sandra
Saxena, Manoj
Shekar, Kiran
Thompson, Kelly
Webb, Steven
Young, Paul J.
Udy, Andrew A.
Abstract
Background
Data on long-term survival after intensive care unit (ICU) admission for sepsis and septic shock are limited. This study aimed to evaluate survival over five years among critically ill sepsis or septic shock patients discharged alive from hospital.
Methods
This retrospective cohort study of adults who survived to hospital discharge after non-elective ICU admission (2018–2024) used Australian and New Zealand Intensive Care Society Adult Patient Database. Sepsis, septic shock, or non-sepsis patients were classified using diagnostic codes and physiological/laboratory criteria during first 24-h of ICU admission. Mixed-effects Cox models with time-varying covariate effects were used, adjusting for demographics, comorbidities, frailty, illness severity, and ICU interventions.
Findings
Of 557,538 hospital survivors, 7.3% had sepsis without shock, 11.5% septic shock, and 81.2% non-sepsis conditions. At five-years, unadjusted survival was lowest for septic shock (68.0%, 95% confidence interval/CI = 67.6–68.4%), sepsis without shock (74.2%, 73.7–74.6%), and non-sepsis (78.2%, 78.1–78.3%). After adjustment, hazards ratio/HR for sepsis without shock remained at or below the null relative to non-sepsis; 0–1 year: HR = 0.95, 0.92–0.98; 1–3 years: 0.96, 0.93–1.00; 3–5 years: 1.03, 0.97–1.08, while septic shock showed persistent independent excess mortality; 0–1 year: HR = 1.05,1.03–1.08; 1–3 years: 1.03, 1.00–1.06; and 3–5 years:1.09,1.05–1.14. Major predictors of mortality included age, frailty, comorbidities, and organ support.
Interpretation
Septic shock was associated with persistent independent excess mortality over five years after hospital discharge, whereas in sepsis without shock, this was largely explained by pre-existing comorbidity and frailty.
Funding
Medical Research Future Fund.
Data on long-term survival after intensive care unit (ICU) admission for sepsis and septic shock are limited. This study aimed to evaluate survival over five years among critically ill sepsis or septic shock patients discharged alive from hospital.
Methods
This retrospective cohort study of adults who survived to hospital discharge after non-elective ICU admission (2018–2024) used Australian and New Zealand Intensive Care Society Adult Patient Database. Sepsis, septic shock, or non-sepsis patients were classified using diagnostic codes and physiological/laboratory criteria during first 24-h of ICU admission. Mixed-effects Cox models with time-varying covariate effects were used, adjusting for demographics, comorbidities, frailty, illness severity, and ICU interventions.
Findings
Of 557,538 hospital survivors, 7.3% had sepsis without shock, 11.5% septic shock, and 81.2% non-sepsis conditions. At five-years, unadjusted survival was lowest for septic shock (68.0%, 95% confidence interval/CI = 67.6–68.4%), sepsis without shock (74.2%, 73.7–74.6%), and non-sepsis (78.2%, 78.1–78.3%). After adjustment, hazards ratio/HR for sepsis without shock remained at or below the null relative to non-sepsis; 0–1 year: HR = 0.95, 0.92–0.98; 1–3 years: 0.96, 0.93–1.00; 3–5 years: 1.03, 0.97–1.08, while septic shock showed persistent independent excess mortality; 0–1 year: HR = 1.05,1.03–1.08; 1–3 years: 1.03, 1.00–1.06; and 3–5 years:1.09,1.05–1.14. Major predictors of mortality included age, frailty, comorbidities, and organ support.
Interpretation
Septic shock was associated with persistent independent excess mortality over five years after hospital discharge, whereas in sepsis without shock, this was largely explained by pre-existing comorbidity and frailty.
Funding
Medical Research Future Fund.
Publication information
Lancet Reg Health West Pac. 2026 July; 72: 101912. doi: 10.1016/j.lanwpc.2026.101912
Date Issued
2026-07-01
Type
Journal Article
Journal Title
The Lancet regional health. Western Pacific
Permanent link to this record
Link to related resource
Owning collection
